A grid of six photos showing children and young people who received gene therapy for ADA-SCID between 2012 and 2019, now living full, healthy lives.
Courtesy of the patients' families
Six of the patients who received gene therapy for ADA-SCID between 2012 and 2019. Now ranging from elementary through high school age, they are living full, healthy lives.